Almirall's nine-month 2007 net sales rise 3.8%

Spain's leading drugmaker, Almirall, achieved net sales of 590.3 million euros ($858.2 million) in the first nine months of 2007, an increase of 3.8% on the comparable period last year, reflecting strong domestic sales as well as income from overseas.

The company's earnings before interest, taxes, depreciation and amortization totalled 159.2 million euros in these nine months, indicating a growth of 21.4% compared to the same period in 2006, mainly due to an increase in sales and other income, and lower general, marketing and sales expenses. During the period, the firm spent 78.3 million euros on the R&D of medicines, up 27.8%.